FDA approves Rocket gene therapy for rare immune disorder - statnews.com

1. FDA approves Rocket gene therapy for rare immune disorder  statnews.com
2. Rocket Pharma shares fall despite FDA nod for childhood disorder treatment  Reuters
3. Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)  Business Wire
4. First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder  GlobeNewswire
5. Rocket charts measured trajectory for new gene therapy Kresladi after clearance to launch from FDA  Fierce Pharma